Answer
Ziihera (zanidatamab) is used alone to treat adults with unresectable locally advanced or metastatic HER2-positive (IHC3+) biliary tract cancer previously treated with at least one line of systemic therapy.
Sources for this answer
- Ziihera 300 mg powder for concentrate for solution for infusionJazz Pharmaceuticals Research UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked